We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SENATORS EYE NEW BILLS TO COMPEL CLINICAL TRIAL REPORTING
SENATORS EYE NEW BILLS TO COMPEL CLINICAL TRIAL REPORTING
July 20, 2004
Two Democratic senators are mulling over the idea of forcing greater compliance with posting requirements on clinical trial drug registries by authorizing the FDA to withhold approval of clinical trial protocols pending a sponsor's commitment to list on the registry.